FDA NDC Directory · JSON-LD · Markdown

Lamzede

NDC 10122-180 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameVelmanase alfa-tycv
Labeler / ManufacturerChiesi USA, Inc.
Marketing categoryBiologic License Application · App BLA761278
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsVELMANASE ALFA-TYCV (10 mg/1)
Marketing started20230301
Package count3

External sources

Source: openFDA. Public-domain (CC0).